Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New signing UTC

"PTSC lives, for yet another day, IMO."

With the drastically reduced costs because of the sell of PDSG and the money on the bank PTSC is able to live another 12 months without any additional cash and wouldn't need another "low-ball licence" AND assuming TPL/Leckrone receives enough money from its/his other patent portfolios - so the question is:

Why did all these companies in 2012 get licences for little money?

Has the overall level of patent license fees decreased?
Or is there a strategic "plan" behind licensing a company for substantial less than we saw in 2006-2008?

GLTA

Share
New Message
Please login to post a reply